LIAISON Anti-HAV
Hepatitis A Test (Antibody And Igm Antibody). 510(k) K210272, from DiaSorin, Inc. (Stillwater, MN). Product code LOL, class 2.
As of Nov 21, 2026, K210272 is an FDA 510(k) held by DiaSorin, Inc., substantially equivalent on Feb 9, 2021 after 8 days, with no recalls tied to it in FDA's recall database.
- Review time: 8 days
- Recalls: 0
- Cited as a predicate by: 1 device
The LIAISON® Anti-HAV assay is an in vitro chemiluminescent immunoassay intended for the qualitative detection of total antibodies to hepatitis A (anti-HAV) in human serum and sodium heparin plasma samples using the LIAISON® Analyzer family.
- LIAISON Anti-HAV AssayK193532 · DiaSorin, Inc. · Mar 2, 2020
- LIAISON Anti-HAV; LIAISON XSK223403 · DiaSorin, Inc. · Dec 9, 2022
- Elecsys Anti-HAV IgMK260048 · Roche Diagnostics · Apr 7, 2026
- Access anti-HAV IgMK251995 · Beckman Coulter, Inc. · Jan 27, 2026
- Access anti-HAVK243846 · Beckman Coulter, Inc. · Sep 9, 2025
- HAVAb IgG IIK222850 · Abbott Laboratories · Aug 10, 2023
- LIAISON Anti-HAV; LIAISON XSK223403 · DiaSorin, Inc. · Dec 9, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Feb 1, 2021
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.3310
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files